J
John L. Bass
Researcher at University of Minnesota
Publications - 93
Citations - 4457
John L. Bass is an academic researcher from University of Minnesota. The author has contributed to research in topics: Heart septal defect & Angioplasty. The author has an hindex of 33, co-authored 90 publications receiving 4286 citations. Previous affiliations of John L. Bass include Tel Aviv University & Children's Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk
Zahid Amin,Ziyad M. Hijazi,John L. Bass,John P. Cheatham,William E. Hellenbrand,Charles S. Kleinman +5 more
TL;DR: The risk of device erosion with ASO is low and complications can be decreased by identifying high‐risk patients and following them closely, as well as identifying high-risk cases, early recognition, and prompt intervention.
Journal ArticleDOI
Catheter Closure of Moderate- to Large-Sized Patent Ductus Arteriosus Using the New Amplatzer Duct Occluder: Immediate and Short-Term Results
Jozef Masura,Kevin Walsh,Basil Thanopoulous,Chen Chan,John L. Bass,Yousef Goussous,Paul Gavora,Ziyad M. Hijazi +7 more
TL;DR: Anterograde transcatheter closure using the new ADO is an effective therapy for patients with a PDA diameter up to 6 mm, and further clinical trials are underway.
Journal ArticleDOI
Balloon dilation angioplasty of aortic coarctations in infants and children.
TL;DR: Balloon dilation angioplasty was attempted nine times in eight infants and children with aortic coarctation and was not associated with mortality or significant morbidity in this group of patients, its role in the management of children with coarCTation is yet to be determined.
Journal ArticleDOI
Balloon dilation angioplasty of hypoplastic and stenotic pulmonary arteries.
TL;DR: While BDA did not restore right-heart pressures and anatomy to normal, it provided significant hemodynamic relief to a group of patients in whom traditional operative management has usually been unsuccessful.
Journal ArticleDOI
Transcatheter Closure of Perimembranous Ventricular Septal Defects Using the New Amplatzer Membranous VSD Occluder: Results of the U.S. Phase I Trial
Yun Ching Fu,John L. Bass,Zahid Amin,Wolfgang Radtke,Wolfgang Radtke,John P. Cheatham,William E. Hellenbrand,David T. Balzer,Qi Ling Cao,Ziyad M. Hijazi +9 more
TL;DR: Transcatheter closure of a PmVSD is technically feasible and seems safe enough in children over 8 kg in weight to warrant continuation of clinical trials to assess the long-term safety and efficacy.